Triple
T2190743
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Darzalex |
E49853
|
entity |
| Predicate | firstApprovedForIndication |
P24561
|
FINISHED |
| Object | treatment of patients with multiple myeloma who have received at least three prior lines of therapy |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: treatment of patients with multiple myeloma who have received at least three prior lines of therapy | Statement: [Darzalex, firstApprovedForIndication, treatment of patients with multiple myeloma who have received at least three prior lines of therapy]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: firstApprovedForIndication Context triple: [Darzalex, firstApprovedForIndication, treatment of patients with multiple myeloma who have received at least three prior lines of therapy]
-
A.
isFirstDrugApprovedFor
chosen
Indicates that a drug is the earliest or original medication approved for treating a particular condition, disease, or indication.
-
B.
FDAApprovalType
Indicates the specific regulatory pathway or category under which a product has been approved by the U.S. Food and Drug Administration.
-
C.
firstStandardApproved
Indicates that an entity is the earliest or initial standard that has received formal approval.
-
D.
hasRegulatoryApproval
Indicates that an entity has received formal authorization or clearance from a relevant regulatory authority to operate, be sold, or be used in a specified context.
-
E.
indicatedFor
Indicates...that one entity (typically a treatment, procedure, or product) is recommended or appropriate for use in relation to another entity (such as a condition, symptom, or patient group).
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a88aaba3c48190b351cab9b26989ff |
completed | March 4, 2026, 7:40 p.m. |
| NER | Named-entity recognition | batch_69abbf9e99f08190892d34485c8f2f25 |
completed | March 7, 2026, 6:03 a.m. |
| PD | Predicate disambiguation | batch_69abbda32d1881909d1fd83a751fb21c |
completed | March 7, 2026, 5:54 a.m. |
Created at: March 4, 2026, 7:46 p.m.